GCEBX
Price
$11.69
Change
-$0.00 (-0.00%)
Updated
Jan 14 closing price
Net Assets
39.15M
GCEPX
Price
$11.70
Change
-$0.00 (-0.00%)
Updated
Jan 14 closing price
Net Assets
39.15M
Interact to see
Advertisement

GCEBX vs GCEPX

Header iconGCEBX vs GCEPX Comparison
Open Charts GCEBX vs GCEPXBanner chart's image
Goldman Sachs Clean Energy Income A
Price$11.69
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets39.15M
Goldman Sachs Clean Energy Income P
Price$11.70
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets39.15M
GCEBX vs GCEPX Comparison Chart in %
View a ticker or compare two or three
VS
GCEBX vs. GCEPX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCEBX is a Hold and GCEPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GCEBX (39.1M) and GCEPX (39.1M) have equal amount of cash in the bank . GCEPX pays higher dividends than GCEBX: GCEPX (1.74) vs GCEBX (1.41). GCEBX was incepted earlier than GCEPX: GCEBX (6 years) vs GCEPX (6 years). GCEBX (1.79) is less costly to investors than GCEPX (1.42). GCEBX (136.00) and GCEPX (136.00) have comparable annual turnover. GCEPX has a lower initial minimum investment than GCEBX: GCEPX (0) vs GCEBX (1000). GCEPX (48.42) and GCEBX (48.16) have marching annual gain over last year. GCEPX return over 5 years is better than : -15.86 vs. GCEBX (-17.31).
GCEBXGCEPXGCEBX / GCEPX
Total Expense Ratio1.250.88142%
Annual Report Gross Expense Ratio1.791.42126%
Fund Existence6 years6 years-
Gain YTD4.4684.464100%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets39.1M39.1M100%
Annual Yield % from dividends1.411.7481%
Returns for 1 year48.1648.4299%
Returns for 3 years1.652.6163%
Returns for 5 years-17.31-15.86109%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BQCNF109.36N/A
N/A
Banque Cantonale Vaudoise
AUDGF2.30N/A
N/A
Audinate Group LTD.
NPPNY9.00N/A
N/A
Nippon Shinyaku Co. Ltd.
VMCUF12.79N/A
N/A
Valuence Merger Corp. I
PVCT0.06N/A
-2.92%
Provectus Biopharmaceuticals, Inc.